Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Brugada's syndrome].

Silvia G Priori1, Marina Cerrone

  • 1IRCCS Fondazione Salvatore Maugeri, Dipartimento di Cardiologia, Università degli Studi, Pavia.

Recenti Progressi in Medicina
|November 19, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sedation Strategies, Drugs, and Protocols Used in Catheter Ablation of Atrial Fibrillation: A Focused Review.

Reviews in cardiovascular medicine·2026
Same author

J-Wave Syndromes: Reconciling the Complexity.

JACC. Clinical electrophysiology·2026
Same author

Inflammatory Hot Phases and Disease Trajectory in Desmosomal Cardiomyopathies.

Circulation·2026
Same author

Gene-based Therapies for Cardiovascular Medicine-Incorporating Molecular Medicine into Contemporary Cardiology.

The Canadian journal of cardiology·2026
Same author

Fibroblast growth factor 21 prevents catecholaminergic arrhythmias in a mouse model of PKP2 arrhythmogenic cardiomyopathy.

Heart rhythm·2026
Same author

Contemporary Perspectives on J-Wave Syndromes: An Expert Consensus Statement.

Journal of arrhythmia·2026

Brugada syndrome, a genetic heart condition, can cause sudden death. Identifying high-risk patients through clinical and genetic factors is crucial for effective management and ICD implantation.

Area of Science:

  • Cardiology
  • Genetics
  • Electrophysiology

Context:

  • Brugada syndrome is an inherited arrhythmogenic disease causing syncope and sudden cardiac death in young individuals with structurally normal hearts.
  • It presents with a characteristic electrocardiogram (ECG) pattern (right bundle branch block and ST elevation in V1-V3), but diagnosis can be challenging due to intermittent ECG changes and limited SCN5A gene mutation detection (20-25%).

Purpose:

  • This review aims to present the clinical and genetic features of Brugada syndrome.
  • It will discuss the most recent diagnostic criteria and the prognostic value of clinical tests, particularly programmed electrical stimulation, for risk stratification.

Summary:

  • Brugada syndrome is characterized by specific ECG findings and is linked to SCN5A gene mutations, though not exclusively.

Related Experiment Videos

  • Diagnosis often requires pharmacological challenges due to intermittent symptoms and ECG patterns.
  • Current management is empirical, with implantable cardioverter defibrillators (ICDs) as the primary life-saving option.

    • Impact:

    • Identifying reliable predictors of adverse outcomes is essential for risk stratification and determining the need for ICD implantation.
    • Understanding prognostic markers can guide clinical management and improve patient outcomes, potentially reducing sudden cardiac death.